Prognostic Proteomics

Prognostic Proteomics is a translational proteomics approach that specifically focuses on identifying and validating protein biomarkers or signatures to predict the likely clinical outcome or disease progression in patients, distinguishing it from diagnostic or therapeutic proteomics by its emphasis on future disease trajectory rather than current state or treatment response.

76

Publications

3.1K

Citations

894

Authors

325

Institutions

Publications per year

2017–2026

48

Authors

894

  1. HM
    Harald Mischak

    Mosaiques Diagnostics and Therapeutics (Germany), Germany

    5 publications · 210 citations

    5

    h-index

  2. PT
    Pinkus Tober‐Lau

    Charité - Universitätsmedizin Berlin, Germany

    4 publications · 399 citations

    4

    h-index

  3. FK
    Florian Kurth

    Charité - Universitätsmedizin Berlin, Germany

    4 publications · 399 citations

    4

    h-index

  4. VD
    Vadim Demichev

    Charité - Universitätsmedizin Berlin, Germany

    4 publications · 399 citations

    4

    h-index

  5. AC
    Archie Campbell

    University of Edinburgh, United Kingdom

    4 publications · 312 citations

    4

    h-index

1–5 of 894

Venues

  1. PLoS ONE

    4 publications · 254 citations

    4

    h-index

  2. Journal of Proteome Research

    JPR · 2 publications · 65 citations

    3

    h-index

  3. Cell Reports Medicine

    1 publications · 33 citations

    2

    h-index

  4. PROTEOMICS - CLINICAL APPLICATIONS

    2 publications · 52 citations

    2

    h-index

  5. Journal of Proteomics & Bioinformatics

    JPB · 1 publications · 13 citations

    1

    h-index

1–5